What does Labophar do?
Labophar is a pharmaceutical company specializing in the development and production of high-quality generic medicines. It focuses on providing affordable healthcare solutions while ensuring compliance with international quality standards. The company is committed to innovation and sustainability in its operations to meet the evolving needs of the healthcare market.
- Activities
- Signals
-
Reporting lossesReporting losses € -376K
The company reported a loss in the latest financial year.
Poor liquidityPoor liquidity 0.68The current ratio is below 1: may be insufficient to cover short-term debt.
Strong equityStrong equity € 2.48MStrong equity provides a buffer against setbacks.
Positive cashflowPositive cashflow € 162KPositive operating cash flow in the latest financial year.
Positive EBITDAPositive EBITDA € 420KPositive EBITDA: operating activities are profitable.
- Shareholders
- Credophar 100%
- Investments
- B+Pharma Belgium 100%, Dgpharma 100%
Financial ratios
|
max) max = w;
}
}
const wClamped = Math.max(120, Math.min(800, max));
colWidths[''] = wClamped;
save && save();
})(event)">
|
2025
max) max = w;
}
}
const wClamped = Math.max(120, Math.min(800, max));
colWidths[''] = wClamped;
save && save();
})(event)">
|
2024
max) max = w;
}
}
const wClamped = Math.max(120, Math.min(800, max));
colWidths[''] = wClamped;
save && save();
})(event)">
|
2023
max) max = w;
}
}
const wClamped = Math.max(120, Math.min(800, max));
colWidths[''] = wClamped;
save && save();
})(event)">
|
2022
max) max = w;
}
}
const wClamped = Math.max(120, Math.min(800, max));
colWidths[''] = wClamped;
save && save();
})(event)">
|
|---|---|---|---|---|
|
€
407K
|
€
408K
|
€
1.48M
|
€
4.41M
|
|
|
€
420K
|
€
437K
|
€
358K
|
€
326K
|
|
|
€
-376K
|
€
-418K
|
€
-463K
|
€
-511K
|
|
|
€
2.48M
|
€
2.85M
|
€
3.27M
|
€
3.73M
|
|
|
28.65%
|
33.12%
|
37.13%
|
33.42%
|
|
|
€
6.17M
|
€
5.76M
|
€
5.54M
|
€
7.20M
|
|
|
|
|
-
|
€
313K
|
Publications 15
All publications- Maatschappelijke Zetel 24/02/2023
- Maatschappelijke Zetel - Ontslagen - Benoemingen 12/12/2022
- Ontslagen - Benoemingen 24/12/2021
- Rubriek Herstructurering (Fusie, Splitsing, Overdracht Vermogen, Enz...) 21/09/2020
- Algemene Vergadering - Statuten (Vertaling, Cordinatie, Overige Wijzigingen, ) - Rubriek Herstructurering (Fusie, Splitsing, Overdracht Vermogen, Enz...) 28/07/2020
Frequently asked questions
Answers to the most common questions about Labophar, based on official government data and the filed annual accounts.
What is the VAT number of Labophar?
The VAT number of Labophar is BE0643.723.177.
When was Labophar established?
Labophar was founded in 30-11-2015.
What is the official address of Labophar?
The official address of Labophar is Kortrijksesteenweg 1091/B Gent 9051.
What is the legal form of Labophar?
The juridical form of Labophar is Public limited company (NV/SA).
What is the annual revenue of Labophar?
The revenue of Labophar for the 2025 financial year was €406,703.
What does Labophar do?
Labophar is a pharmaceutical company specializing in the development and production of high-quality generic medicines. It focuses on providing affordable healthcare solutions while ensuring compliance with international quality standards. The company is committed to innovation and sustainability in its operations to meet the evolving needs of the healthcare market.
Is Labophar a reliable company?
Labophar is a registered Rechtspersoon with company number 0643.723.177 and can be verified through the official CBE database.
What is the credit limit of Labophar?
The estimated credit limit of Labophar is €518,427.
Is Labophar still active?
Labophar currently has the status "Normal situation" and is active.